*CAENORHABDITIS ELEGANS* has been a flagship model organism for over 40 years, and the research community has harnessed it to explore a wide range of biological questions, including but not limited to cell death, developmental timing, genome defense, neurobiology, and aging. The value of *C. elegans* as a model was not diminished by the lack of genetic tools. However, recent technological advances that enable genome editing, transcriptional and translational manipulation, *in vivo* labeling, and cell-specific proteomics have opened new avenues of investigation. Thanks to significant investment of time and resources, *C. elegans* now has an extensive toolkit to facilitate these studies.

In recent years, the global health burden of parasitic nematodes has gained wide attention, as they infect over a billion people ([@bib55]; [@bib85]). Infection is rarely fatal, but those who are infected can suffer from debilitating symptoms. Helminth infection depresses human health, cognition, and productivity, and increases the severity of other common diseases caused by viruses and bacterial pathogens including HIV, malaria, and tuberculosis ([@bib55]; [@bib85]). Furthermore, nematodes also parasitize crops and livestock, causing huge losses in production ([@bib58]; [@bib110]). The World Health Organization (WHO) has listed certain parasite infections as targets for eradication by the year 2020 ([@bib56]; [@bib9]; [@bib61]). Efforts to define eradication strategies can be challenging; many parasites have intricate lifecycles with specific host and vector requirements, which in contrast to *C. elegans*, has limited the types of molecular analyses that can be performed. Recognizing the urgency and scope of these issues, both the *C. elegans* and the parasitic nematode communities have responded by bringing together the expertise and knowledge of their respective organisms; at two recent international *C. elegans* meetings, there were workshops to bridge the divide between *C. elegans* researchers and parasitologists. Furthermore, additional funding opportunities have been created, such as the Faucett Catalyst grant in 2013.

In this "toolbox" review I will: (i) outline the state of technology in several commonly studied parasitic nematodes, which could be employed by *C. elegans* researchers looking to translate their findings into a biomedically relevant parasite; (ii) highlight tools from *C. elegans* that could be valuable to parasitologists; and (iii) briefly discuss research areas that can be opened by developing these tools. I will focus on two technologies: fluorescent reporters and the CRISPR/Cas9 system for genome editing.

Lessons Learned from Import into Nonparasites {#s1}
=============================================

Beautiful evolution-development and population genetics research has come from using *C. elegans*, related *Caenorhabditis* species, and other nonparasitic nematodes such as *Pristionchus pacificus*. A major impediment to advancing these studies was the lack of genetic tools in these nonparasitic species. It is therefore instructive to examine the barriers faced by researchers seeking to develop *C. briggsae* and other nonparasitic species as genetic models. Hindsight allows for the identification of particularly successful adaptations, informing fruitful lines of inquiry.

[@bib133] astutely noted that it typically takes years to build a collection of tools, even those as basic as isolated marker mutations and genetic balancers. Bioinformatic resources such as an annotated genome sequence and single nucleotide polymorphism maps were key in driving development of *C. briggsae* as a genetic model. The acquisition of a [Cbr-unc-119](http://www.wormbase.org/db/get?name=WBGene00006843;class=Gene) mutation from a genetic screen provided a selectable marker to permit ballistic transformation and generation of fluorescent reporter strains ([@bib146]). Similarly, *P. pacificus* has a sequenced genome and a well-developed toolkit consisting of forward genetic approaches and DNA transformation ([@bib54]; [@bib27]; [@bib112]; [@bib17]; [@bib119]; [@bib137]).

The development of these genetic models has been greatly facilitated by development of site-specific DNA endonucleases to permit genome editing. First, zinc finger nucleases and transcription activator-like effector nucleases (TALENs), and now clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 ([@bib138]; [@bib81]; [@bib133]) provide researchers the ability to inactivate genes or to knockin desired sequences. Zinc finger nucleases were expensive and required complex algorithms to design, while TALENs were cost effective but somewhat laborious to generate. CRISPR/Cas9 editing has largely supplanted these technologies based on its simplicity, modularity, cost effectiveness, and ease of generating new reagents. CRISPR is an adaptive bacterial immune system that uses a DNA endonuclease to destroy incoming foreign DNA (for a more detailed description see [@bib87]). For genome editing approaches, one uses a simplified system consisting of the Cas9 nuclease and a single guide RNA (sgRNA), which performs the combined function of two small RNAs (CRISPR RNA (crRNA) and trans-activating crRNA (trcRNA)) in the *Streptococcus pyogenes* CRISPR/Cas9 defense ([@bib57]; [@bib108]). Cas9--sgRNA complexes target 5′-(N20)NGG-3′ motifs in the genome ([@bib87]; [@bib57]) ([Figure 1A](#fig1){ref-type="fig"}). The 20 base pairs at the 5′ end of the sgRNA are homologous to this (N20) sequence and base pair with the opposite strand ([Figure 1A](#fig1){ref-type="fig"}). The NGG sequence, known as a protospacer adjacent motif (PAM), is in the genomic target but not the sgRNA and stimulates Cas9 to make a DNA double-stranded break between the third and fourth base 5′ to the PAM ([Figure 1A](#fig1){ref-type="fig"}). One can introduce Cas9 and sgRNAs as: (i) ribonucleoprotein (RNP) complexes; (ii) *in vitro* transcribed RNA; or (iii) encoding double-stranded DNA (dsDNA) molecules such as plasmids or PCR products.

![CRISPR/Cas9 editing. (A) The Cas9:sgRNA complex scans the genome searching for "NGG" PAM sequences (blue text). The 20 bp at the 5′ end of the sgRNA are homologous to the 20 bp 5′ to the PAM in the genomic target site, and the sgRNA pairs with the complementary strand in the genomic target sequence. The PAM sequence instructs Cas9 to make a DNA double-stranded break (DSB) three to four nucleotides 5′ to the PAM. (B) A Cas9-induced DSB can be repaired through error-prone nonhomologous end joining (NHEJ) or error-free homologous recombination (HR) pathways. NHEJ can be used for gene inactivation, as it produces small, random insertion and deletion mutations at the DSB site. By supplying repair templates with homology arms flanking the break site, one can use HR to precisely delete sequences, insert epitopes, or introduce point mutations. To recover HR-mediated knock-ins, one must often either screen large numbers of cells/animals or use positive selection/co-CRISPR approaches; HR is typically less efficient at producing edits compared to NHEJ.](1279fig1){#fig1}

For relatively closely related nematodes, DNA-based CRISPR reagents might be directly imported; Cas9 and sgRNA expression plasmids from *C. elegans* displayed activity in *C. briggsae* ([@bib19]). For more distantly related nematodes, an advantage of Cas9--sgRNA *in vitro* transcription ([@bib14]; [@bib81]) and RNPs ([@bib15]; [@bib102]) is that they do not require the *a priori* knowledge of promoters and 3′-UTRs required to express Cas9 or sgRNAs from plasmids or linear dsDNA molecules. Notably, the first genome editing approaches in *Caenorhabditis* sp. 9 and *P. pacificus* used *in vitro* transcribed TALENs as opposed to DNA-based delivery ([@bib138]; [@bib81]). With respect to CRISPR/Cas9, delivery of *in vitro* transcribed RNA may not be ideal, as Cas9 messenger RNA (mRNA) must be translated while the sgRNA must then complex with the resulting protein product. The window of editing activity is therefore determined by the half-life of the *in vitro* transcribed sgRNA, the time required to translate Cas9, and the stability of Cas9. A recent report described an RNP-based editing approach in *P. pacificus* using Cas9 protein and *in vitro* transcribed sgRNA ([@bib137]). This experimental setup likely represents the highest possible editing efficiency, as a similar approach in *C. elegans* reported highly efficient genome editing ([@bib102]). However, this approach requires large amounts of Cas9 protein and pure RNA, which can be purchased commercially, though could be cost prohibitive for some groups. Alternatively, labs equipped for biochemistry and planning to do significant amounts of genome editing can make their own Cas9 and T7 RNA polymerase ([@bib36]; [@bib102]), greatly reducing cost.

In the path to developing *C. briggsae* and *P. pacificus* as model systems, key steps were the development of DNA transformation approaches, an annotated genome and transcriptome, and the cognate bioinformatic tools required to mine these resources. These investments are essential to realize the true potential of any parasitic nematode as a model.

Key steps in developing a nematode as a model {#s2}
---------------------------------------------

-   Annotated genome and transcriptome

-   Method(s) of transgenesis

-   Genome editing to enable rapid genetic analyses

Existing Technologies in Parasites {#s3}
==================================

The number of nematodes with sequenced genomes is ever expanding, due to efforts of many groups such as the 959 Nematode Genomes Project ([@bib69]), the 50 Helminth Genomes Initiative, and the Filarial Worms Genomes Project. Nematode.net ([@bib139]; [@bib88]), and WormBase ParaSite ([@bib76]) provide useful tools for navigating these sequences. Importantly, the plummeting cost and increasing sensitivity of high throughput sequencing allow analyses of the genome, transcriptome, or variome of a given parasite, provided clean DNA or RNA can be obtained. For example, these tools have led to insight in RNA interference (RNAi) and microRNA (miRNA) biology in a range of nematodes ([@bib20]; [@bib128]; [@bib135]; [@bib3]; [@bib103]; [@bib111]), discovery of parasite-secreted RNAs that can modulate host biology ([@bib10]; [@bib143]), and led to revelation that germline-expressed genomic DNA is lost in *Ascaris suum* somatic cells ([@bib129]).

In contrast to these genomic/transcriptomic approaches, powerful genetic tools, such as transgenesis, RNAi, and CRISPR editing, rely on parasite culture. In this section, I will highlight the most useful genetic tools of several species of parasites (*Strongyloid* spp., *Brugia malayi*, and *A. suum*) noting that *Strongyloid* species provide the most advanced toolkit; tools in other parasites currently lag far behind.

Strongyloides spp.: the most sophisticated toolkit {#s4}
--------------------------------------------------

*Strongyloides* spp. are soil-dwelling helminths with complex lifecycles involving alternation of free-living and parasitic stages (heterogony). Infectious L3 (iL3) stage larvae residing in the soil burrow through the skin of their host, migrate to alveolar macrophages, are coughed up, and swallowed. During this migration, they molt twice so that adult nematodes reside in the gut where the parthenogenic parasite females produce eggs ([Table 1](#t1){ref-type="table"}). These eggs are either shed in feces or hatch within the intestine. The shed eggs hatch outside the host and either directly develop to iL3 larvae, the parasitic stage, or enter an alternate, free-living stage ([@bib126]). For most species of *Strongyloides*, there is a single free-living generation, and all progeny of the males and females develop to iL3 ([@bib126]). Interestingly, the felid parasite *Strongyloides planiceps* can undergo several sequential free-living generations, with the proportion of iL3 progeny increasing in each generation until no more free-living animals are produced ([@bib142]).

###### *Strongyloides* spp. overview

  Lifecycle                                                                                                                                         Health burden                                                          Transgenesis                                              Genetic tools
  ------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------
  • iL3 larvae penetrate skin, make it to small intestine                                                                                           • Estimated 30--100 million infected                                   • Gonadal microinjection of adults ([@bib77]; [@bib78])   • Promoter:fluorescent protein reporters ([@bib77]; [@bib78]; [@bib59]; [@bib123])
                                                                                                                                                                                                                                                                                     
  • Adults produce larvae that are shed in stool                                                                                                    • Asymptomatic to mild manifestations in skin, lung, and intestines                                                              • Transposons for insertional mutagenesis and stable transformation ([@bib116])
                                                                                                                                                                                                                                                                                     
  • Larvae excreted into the environment can either develop directly into iL3 or enter a free-living stage, developing to adults outside the host   • Infection can be life threatening in immunocompromised individuals                                                             
                                                                                                                                                                                                                                                                                     
  • *S. stercoralis* larvae in large intestine can autoinfect by penetrating the intestine wall and migrating back to small intestine                                                                                                                                                

The free-living larvae develop to adulthood and mate to produce eggs, which hatch and develop to i L3 larvae. In the case of *Strongyloides stercoralis*, autoinfection cycles are possible. Eggs can hatch inside the intestine, develop to iL3 larvae, penetrate the intestinal mucosa or perianal skin, and migrate randomly to other organs. If these larvae migrate to the intestine via the lungs, the infection cycle can begin anew ([@bib82]; [@bib126]). Importantly, there is a free-living cycle in soil that is exploited in the lab to culture the parasites for one generation outside of a host ([@bib126]). *S. stercoralis* (dog or gerbil host) and *S. ratti* (rat host), two species commonly studied in the lab, both can be transformed by gonadal microinjection ([@bib77], [@bib78]). A gene expression "toolkit" has been constructed for *S. stercoralis* using a *gfp*S65C gene from a *C. elegans* expression system and the *S. stercoralis era-1* 3′-UTR ([@bib77], [@bib78]); cloning *S. stercoralis* promoter sequences into this vector allows for cell- and tissue-specific expression of GFP. This system was further refined by making it Gateway (Invitrogen) cloning compatible, allowing researchers to combine any promoter, coding sequence, and 3′-UTR to create expression vectors ([@bib123]). In *S*. *ratti*, adaptation of the *piggyBAC* transposon system, commonly used in *Drosophila melanogaster*, allows for insertional mutagenesis and stable integration of transgenes ([@bib116]). Notably, toggling between *C. elegans* and *Strongyloides* spp. has provided insight into genetic control of developmental transition to the iL3 stage ([@bib130], [@bib131]; [@bib121],[@bib122]; [@bib123]). *Parastrongyloides trichosuri*, a parasite of Australian possums of the genus *Trichosurus*, has great promise as a model for *Strongyloides* ([@bib47]). Unlike *S. ratti* and *S. stercoralis*, *P. trichosuri* can be maintained in a free-living state in the absence of a host for over 90 generations ([@bib47]), and gonadal microinjection of DNA can produce heritable transgenesis ([@bib46]).

*Brugia*: National Institutes of Health core funding driving tool development {#s5}
-----------------------------------------------------------------------------

*Brugia* species belong to the filarial nematode family, members of which cause lymphatic filariasis (*B. malayi*, *B. timori*, and *Wuchereria* *bancrofti*) and subcutaneous filariasis (*Loa loa*, *Mansonella streptocerca*, *Onchocerca volvulus*) in humans. Dog heartworms *(Dirofilaria* *immitis*), an important parasite from a veterinary perspective, are also filarial nematodes. Interestingly, many members of this family carry *Wolbachia pipientis* as an obligate endosymbiote ([@bib100]). I will focus on *Brugia malayi*, as it has the most sophisticated toolkit. Disease caused by this parasite can range from asymptomatic to acute episodes of inflammation involving skin, lymph nodes, and lymphatic vessels ([@bib12]) ([Table 2](#t2){ref-type="table"}). The parasite is transmitted by a mosquito vector; next, a specialized L1 stage (microfilariae) is taken up by mosquitoes in a bloodmeal ([@bib100]). The microfilariae shed an extracuticular sheath to become proper L1s and migrate to the thoracic muscle where they molt twice to become L3 larvae ([@bib100]). The L3 larvae migrate to the mosquito's head and enter the human host when taking a bloodmeal. The L3s molt twice in unknown locations in the human host to become adults, which reside in the lymphatic system and produce an average of 10,000 microfilariae a day ([@bib100]).

###### *B. malayi* overview

  Lifecycle                                                                                   Health burden                                                   Transgenesis                                                                                        Genetic tools
  ------------------------------------------------------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  • L1--L3 in mosquito, L4--adult in mammalian host                                           • 120 million with lymphatic filariasis                         • Bombardment of embryos and adult females ([@bib52])                                               • Luciferase reporters in embryos and L3s ([@bib141])
                                                                                                                                                                                                                                                                  
  • Adults live in lymphatic vessels                                                          • *B. malayi* causes 20 million of these cases                  • Gonadal microinjection of adult females ([@bib52])                                                • Immunofluorescence ([@bib73])
                                                                                                                                                                                                                                                                  
  • Adult females can release up to 10,000 of specialized L1 larvae (microfilariae) per day   • Disfiguring lymphodema, elephantiasis, and scrotal swelling   • Calcium phosphate precipitate-mediated transformation of L3s *in vivo* or *ex vivo* ([@bib141])   • RNAi: on adult females to knock down embryo gene expression ([@bib2]; [@bib73]); on L3 larvae *ex vivo* ([@bib70]); on L2 and L3 larvae *in vivo* (in mosquito vector; [@bib120]); Note RNAi may be variable in efficiency

In 1969, Dr. Paul Thompson was awarded a National Institutes of Health (NIH) contract to establish the Filariasis Research Reagent Resource Center (FR3) to supply worms for his studies and those of other researchers ([@bib93]). Currently funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH, the FR3 maintains the lifecycle of *B. malayi*, *B. pahangi*, *D. immitis*, and the rodent parasite, *Acanthocheilonema vitae*. The role of distributing these reagents has recently been passed onto Biodefense and Emerging Infections Research Resources Repository (BEI Resources), which the NIAID established to provide reagents and tools for the study of a range of pathogens, emerging infectious disease agents, and nonpathogenic microbes. BEI ships parasites, vectors, and molecular and serological reagents at no cost. The FR3 and BEI have provided the single greatest value to lymphatic filariasis infection research, providing reagents to researchers around the globe. These resources have driven progress in these filarial nematodes, as otherwise facilities for rearing both the mosquito vector and mammalian host, typically jirds, would be required.

Tool development in *B. malayi* has been enabled by the range of DNA transformation techniques available: microinjection in adult females ([@bib52]), bombardment of adult females and embryos ([@bib52]), and calcium phosphate precipitate-mediated transformation of L3 larvae in cell culture media *ex vivo* or in jird peritonea *in vivo* ([@bib141]). Available tools include: (i) immunofluorescence ([@bib73]); (ii) secreted *Gaussia* luciferase ([@bib141]) and nonsecreted firefly and Renilla luciferase reporters ([@bib79]), which can be used to study various aspects of gene expression, including miRNA control ([@bib80]); and (iii) RNAi *ex vivo* on adult females to interrogate embryo gene function ([@bib2]; [@bib73]), on L3 larvae *ex vivo* ([@bib70]), and *in vivo* in the mosquito vector to target L2 and L3 larvae ([@bib120]). It is important to note that in many parasitic nematodes, including *Brugia* spp., RNAi efficacy is extremely variable, with robust knockdown only observed for a limited number of genes ([@bib40]; [@bib89]; [@bib21]). A recent RNAi protocol using heterogenous short interfering RNAs (hsiRNAs) has shown promise in knocking down a number of genes in the hands of two different groups ([@bib73]; [@bib136]); however, more positive results are required to confirm the broad applicability of this tool.

*B. pahangi*, a canid parasite very similar to *B. malayi*, is often used to study *Brugia* biology, as: (i) it is easier to get large amounts of the parasite, (ii) the tools listed above should also work in *B. pahangi*, (iii) it has a sequenced genome ([@bib74]), and (iv) it does not typically infect humans. Many researchers prefer working with *B. pahangi*, as the microfilariae can be harvested from dogs, unlike *B. malayi*, in which microfilariae are harvested from cats, which can be difficult to handle (J. Sakanari, personal communication).

*Ascaris*: a big target {#s6}
-----------------------

*Ascaris* are large nematodes, up to 35 cm long, that infect pigs (*A. suum*) and humans (*A. lumbricoides*); notably, cross-infection is possible ([@bib30]). Most work has been done with *A. suum*, primarily owing to the availability of samples from the pork industry. *A. suum* can infect its host directly through contaminated food or water or via a paratenic host ([@bib30]) ([Table 3](#t3){ref-type="table"}). The pig ingests eggs with L2 larvae, which then hatch and then undergo hepatic migration ([@bib30]). These larvae molt to L3, migrate to the lungs where they enter alveoli, are coughed up, and swallowed ([@bib30]). Finally in the gut, they molt twice to become adults and mate; adults produce upwards of 200,000 eggs per day ([@bib30]).

###### *Ascaris* spp. overview

  Lifecycle                                                                                                           Health burden                                                                             Transgenesis                            Genetic tools
  ------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- --------------------------------------- -----------------------------------------------------------------------------------
  • After ingestion of infective eggs, larvae hatch, penetrate intestine wall, and migrate to lungs by way of liver   • Estimated 800--1000 million infected with *A. lumbricoides*                             • Bombardment in *A. suum* ([@bib23])   • Whole *A. suum* embryo extracts for biochemistry ([@bib49]; [@bib24]; [@bib72])
                                                                                                                                                                                                                                                        
  • Larvae develop further, are coughed up, swallowed, and develop to adults in the small intestine                   • Asymptomatic to light abdominal discomfort                                                                                      • RNAi by microinjection into *A. suum* pseudocoelom ([@bib90])
                                                                                                                                                                                                                                                        
  • Adult females can release up to 200,000 eggs per day                                                              • Heavy infections can cause intestinal blockage and stunt child development and growth                                           

The large size of *Ascaris* makes it amenable for biochemical studies. Whole cell embryo extracts have been used for *in vitro* studies of transcription, RNA processing, and translation, and have provided much initial insight into nematode splicing ([@bib49]; [@bib23]; [@bib24]; [@bib72]). Fertilized zygotes arrest before pronuclear fusion, allowing storage of large numbers of embyos for years at 4°, which can then be synchronously released by exposure to an acidic environment that mimics the host stomach (R. E. Davis, personal communication). Postfertilization cell cycles are slow (13 hr, compared to 30 min in *C. elegans*) ([@bib6]), allowing for excellent temporal resolution of early development. Although pigs are needed to maintain the lifecycle, embryonic and early larval development can be studied *in vitro*, and migration from the intestine to the liver and lungs can be studied in rabbits, mice, or rats ([@bib11]; [@bib37]; [@bib31]). From a toolkit perspective, transient transformation is possible by bombardment, usually at the 32- to 64-cell stage, thereby introducing DNA or RNA into embryos ([@bib23]). Excitingly, a recent report described a protocol in *A. suum* in which pseudocoelemic microinjection of dsRNA produced robust knockdown of multiple target transcripts in a range of tissues throughout the animal ([@bib90]). Exposure to *Ascaris* pseudocoelomic fluid can cause acute, severe allergic reactions in some laboratory workers ([@bib64]; [@bib65]; [@bib63]) and has resulted in some researchers moving to other systems (A. Fire, personal communication).

Other Nematodes of Significant Interest and Importance {#s7}
======================================================

While I have focused on three parasitic nematode species with the best genetic toolkits (*Strongyloides* spp., *Brugia* spp., and *A. suum*), I stress that there are numerous other important parasitic nematodes not discussed in this review ([@bib55]; [@bib58]; [@bib110]); many of these have complete, annotated genomes, or sequencing of those genomes is in progress. In this section, I will highlight several clinically or economically important species of nematodes and provide references for the reader to find information about these parasites.

Soil-dwelling helminths such as hookworm (*Ancylostoma duodenale* and *Necator americanus*) or whipworm (*Trichuris trichiura*) are important human pathogens that each infect hundreds of millions ([@bib85]). A relative of *T. trichiura* that infects mice (*T. muris*) is a useful laboratory model for study of whipworms and used as a model gastrointestinal nematode for immunological studies ([@bib34]). Parasites of livestock and crops pose an equally important problem to human well-being. *Haemonchus contortus* is the central model species for strongyloid parasitic nematodes of livestock, and provides a paradigm to study emergence of anthelmintic resistance ([@bib42]). Notably, *C. elegans* has been successfully used as a heterologous system to functionally characterize *H. contortus* genes (for example, see [@bib44]). *Ostertagia ostertagi* is a gastrointestinal parasite of cattle and arguably the most important livestock parasite globally ([@bib109]). *Toxocara canis* is emerging as an important zoonosis and has good genomic resources ([@bib39]; [@bib147]).

Plant parasitic nematodes compromise global food security, causing an estimated US\$80 billion in losses per year ([@bib95]). The rootknot nematodes (*Meloidogyne* spp.) attack a wide range of plants, including many common vegetables. The second juvenile stage (J2) of this parasite creates a permanent feeding site on the affected plant root, leading to formation of several giant cells on which the sedentary J2 animal extracts nutrients. Two rootknot nematodes, *Meloidogyne hapla* and *M. incognita*, have sequenced genomes that provided insight into the adaptations and genes required for their obligate parasitic lifecycle ([@bib1]; [@bib99]). Cyst nematodes (*Heterodera* and *Globodera* spp.) are important pests for a range of crops, such as members of the Solanaceae family (*i.e.*, potatoes and tomatoes), sugar beets, soy beans, and cereals; these parasites cause significant agroeconomic loss ([@bib58]). Of the cyst nematodes, the potato cyst nematode (*Globodera pallida*), has a sequenced genome ([@bib18]); the soybean cyst nematode (*Heterodera glycines*) and sugar beet cyst nematode (*Heterodera schachtii*) genomes are in the process of being sequenced. There is a range of other important plant parasitic nematodes, nicely reviewed by [@bib58]. Notably, unlike animal and human parasitic nematodes, RNAi appears to work very well in a range of plant parasitic nematodes, offering the possibility of genetic study ([@bib89]). Nematodes can also be beneficial to agriculture ([@bib71]); entomopathogenic nematodes such as *Steinernema* spp. ([@bib28]) or *Heterorhabditis bacteriophora* ([@bib7]) target a wide range of insect pests.

*C. elegans* Tools: Low Hanging Fruit Ripe for Picking {#s8}
======================================================

For all tools that I will describe, a system for transgenesis is a prerequisite; the system does not need to be elegant, one just needs to get DNA, RNA, or protein into the organism ([Figure 2](#fig2){ref-type="fig"}). Gonadal microinjection, bombardment, electroporation, or transformation are all possibilities. The observation that *B. malayi* L3 larvae can be transformed in culture may allow transformation/transfection methods commonly used in mammalian cells to be used in particular nematodes at select stages (*i.e.*, cationic lipids, recently described iTOP for protein delivery) ([@bib22]). Nematodes that can be coaxed to molt in culture may be more susceptible to these transfection approaches ([@bib107]; [@bib141]). Notably, many important nematodes such as hookworms, whipworms, and plant parasitic nematodes currently do not have established DNA transformation protocols. As such, a significant investment is required to overcome this crucial barrier to further genetic and molecular study. However, the reward for doing so is great: these particular parasites pose a significant burden to human health and agriculture, the barrier is surmountable, and there is enormous potential for advancing the field using the tools that follow. In the following sections, I will outline several technologies that should be transferable to any nematode for which transformation is possible: reporters for gene expression and protein localization, methods to enrich transgenic animals, and last but certainly not least, genome editing with CRISPR/Cas9, which could greatly accelerate research into these diverse and biomedically and economically relevant organisms. Importantly, for those interested in developing these tools in a parasitic nematode, many of the *C. elegans* reagents have been deposited in AddGene, a nonprofit plasmid repository.

![Recommended pipeline for technology import into parasitic nematodes. One should start with a parasitic nematode species that has an annotated genome or transcriptome or generate these datasets. For the described genetic tools, a method of transgenesis is a prerequisite. Promoter:FP reporters should be used to characterize regulatory elements, and monitor gene expression, temporally and spatially. The regulatory elements characterized through the FP reporters are useful for development of selection systems and CRISPR editing approaches. Positive selection systems, such as drug resistance or FP reporter expression, help identify transgenic animals. Drug selection cassettes are preferable, as they could allow for *in vivo* selection of transgenic parasites in host animals. For CRISPR approaches, it is best to start with activation or repression of gene expression using CRISPRa or CRISPRi, respectively, or generation of indel mutations using somatic CRISPR editing. These approaches should work in first generation transgenic animals, circumventing issues with requisite host passage. If these methods are robust, the lifecycle can be maintained, and once a positive selection system is in place, one can attempt to generate stable knockouts or knockins. A gene drive system is recommended, with appropriate safeguards, to create homozygotes in first generation transgenics, and subsequently in any genetic background to which the transgene is introduced.](1279fig2){#fig2}

Look to your neighbors {#s9}
----------------------

Before starting, a phylogenetic perspective ([@bib8]; [@bib53]) may be instructive for gauging how likely a given methodology from *C. elegans* is to work in a given parasite. Clade V nematodes such as hookworms may be more successful recipients than clade III nematodes, such as *Brugia* spp., or clade IV nematodes, such as *Strongyloides* spp. Indeed, *C. elegans* has been a useful system to study aspects of *H. contortus* (Clade V) gene function (for examples, see [@bib44]; [@bib75]). Another important consideration is to learn from other free-living models ([@bib83]). The modifications required for development of a transgenesis method in *P. pacificus* were useful to improve methodologies in *Strongyloides* spp. ([@bib83]). As nicely observed by [@bib83], the necromenic association of *P. pacificus* with the scarab beetle requires many of the "same crucial functions and life-cycle transitions that medically important parasitic nematodes execute in their vertebrate hosts." Looking to these free-living models may help identify optimal conditions for generating lines of nematodes that stably express and inherit transgenes.

Reporter systems: an engine to drive other technologies {#s10}
-------------------------------------------------------

Developing reporter systems such as luciferase, beta-galactosidase (LacZ), or fluorescent proteins (FPs) are useful for two reasons: (i) they provide experimental information on putative regulatory DNA sequences, and (ii) they provide information on tissue- and stage specificity of gene expression. Obtaining a collection of validated promoters and 3′-UTRs is essential for developing DNA-based expression systems to drive cotransformation markers and express genes of interest. To date luciferase reporters have been used in *B. malayi* and fluorescent reporters such as GFP ([@bib77]; [@bib78]; [@bib141]; [@bib123]) and mRFPmars ([@bib59]) have been employed in *Strongyloides* spp. The use of luciferase reporters in *B. malayi* has provided valuable information about splicing, gene regulation by the ecdysone receptor, and study of select promoters ([@bib118]; [@bib51]; [@bib124]). Firefly luciferase was initially used to identify regions of the HSP70 promoter required for transgene expression ([@bib118]), though a caveat of this approach is that animals must be homogenized for the assay. *Gaussia* luciferase, a secreted variant, can be measured in live animals thus allowing for monitoring of promoter activity *in vivo* ([@bib141]). However, luciferase reporters cannot be used to examine spatial expression patterns.

LacZ is a very sensitive reporter gene, and it can be used to gauge expression patterns *in vivo*, but the animals must be fixed ([@bib33]). Of note, LacZ reporters have been validated in transgenic *Parastrongyloides trichuris* ([@bib46]). Beware that there may be issues with endogenous beta-galactosidase expression, which can result in spurious background signal, particularly if the endogenous beta-galactosidase is activated at the slightly alkaline pH resulting from the fixation process ([@bib134]).

The reporters of choice in *C. elegans* are fluorescent proteins. FPs can be scored in living animals, enabling the collection of temporal and spatial expression data for both genes and proteins. A catalog of regulatory elements has been exploited to drive gene expression constitutively, inducibly, or in a temporally and spatially defined pattern. Autofluorescence may interfere with imaging in parasites, but the palette of FPs used in *C. elegans* continues to expand, virtually guaranteeing a solution to meet the needs of the model. Directed selection of mutant variants of the original GFP from *Aequorea victoria* and FPs from other organisms, such as *Discosoma* sp. ([@bib114]), led to the creation of red, yellow, and green FPs, as well as ultrabright FPs (3xVenus, mNeonGreen, tdTomato ([@bib94]; [@bib114]; [@bib50]; [@bib115]) and photostable FPs that cover a range of wavelengths (far red, near IR, blue, cyan, orange). In selecting promoters for expression of FPs in desired spatial patterns, one should make educated decisions based on multispecies alignments to identify conserved regulatory elements, and/or make use of existing RNA-seq data. For example, the promoter and 3′-UTR of the BmHsp70 gene drive luciferase reporter activity ([@bib118]), and RNA-seq data confirm high expression of this transcript ([@bib16]). Adding two copies of a nuclear localization sequence to drive nuclear expression of the FP, or three copies to drive nucleolar expression, can concentrate the FP to facilitate cell identification and visualization. Fusion of FPs to proteins of interest allows for live *in vivo* monitoring of protein localization, though the large size of the FP tag can potentially interfere with protein function or interaction with endogenous partners; occasionally one will need to try several different fusion locations of the FP within the protein of interest.

There are important caveats to be aware of, gleaned from the extensive use of FP reporters in *C. elegans*. While promoters provide temporal and spatial control of gene expression, FPs do not always require a promoter for expression (A. Fire, personal communication). They do, however, require a *C. elegans* 3′-UTR. The *[unc-54](http://www.wormbase.org/db/get?name=WBGene00006789;class=Gene)* 3′-UTR was used initially, and is still frequently used ([@bib33]). More recently, the *[let-858](http://www.wormbase.org/db/get?name=WBGene00002957;class=Gene)* 3′-UTR ([@bib62]), which results in uniform expression across cell types, and the *[tbb-2](http://www.wormbase.org/db/get?name=WBGene00006537;class=Gene)* 3′-UTR ([@bib92]), which permits germline expression of transgenes, have also been used. Introns are important for expression in *C. elegans*, and often short, synthetic introns are added to genes to facilitate expression ([@bib33]). More recently developed LacZ reporters containing multiple synthetic introns are much more active in *C. elegans* than the original single intron LacZ reporter (A. Fire, personal communication). The same trend of increased expression with more introns is also true for GFP, but less dramatic, likely due to the shorter size of the GFP mRNA (A. Fire, personal communication). It is unclear whether these *C. elegans* synthetic introns will work in all parasites, but the *C. elegans gfp65C* cassette, which contains three synthetic introns, expresses in *Strongyloides* spp., a nematode highly diverged from *C. elegans* ([@bib8]; [@bib77], [@bib78]). As introns could differ extensively, whether *C. elegans* FP cassettes can be directly used in a given parasite needs to be assessed on a case-by-case basis.

Enriching for transgenics {#s11}
-------------------------

Once transgenesis and FP reporters are established in a model nematode, the next step is to develop methods to maintain and enrich for transgenic animals. In *C. elegans*, transgenic animals were initially selected by using phenotypic markers, such as *[rol-6](http://www.wormbase.org/db/get?name=WBGene00004397;class=Gene)([su1006](http://www.wormbase.org/db/get?name=WBVar00248869;class=Variation))* ([@bib68]), which produced visible changes in transgenic animals (*i.e.*, rolling in a circle) ([@bib91]). These phenotypic markers are identified through laborious genetic screens. Moreover, phenotypic markers could impair processes such as invasion, migration, and establishment in the host that are critical for propagation as transgenics. Markers in *C. elegans* and *P. pacificus* such as dominant *[rol-6](http://www.wormbase.org/db/get?name=WBGene00004397;class=Gene)* could impair parasite motility to the point where the worms are innocuous ([@bib67]; [@bib112]; [@bib5]). Promoter:FP reporters were used next, in which transgenic animals had all cells labeled with the FP ([@bib48]), or FP expression in specific cell types (*i.e.*, pharyngeal muscle or body-wall muscle; [@bib98]). Maintenance of lines carrying either phenotypic or FP cotransformation markers requires manual picking of marker positive animals, which can be labor intensive for experiments that require large amounts of transgenic animals. Instruments such as the COPAS Biosort (Union Biometrica) may allow for enrichment of transgenic animals through automated separation of fluorescent and nonfluorescent animals; transgenic iL3 *S. stercoralis* larvae were selected from a mixed stage population using this instrument ([@bib59]). Historically, to select for transgenic animals with minimal effort, rescue of mutants that displayed phenotypes such as temperature-sensitive embryonic and larval lethality (*[pha-1](http://www.wormbase.org/db/get?name=WBGene00004010;class=Gene)*([*e2123*](http://www.wormbase.org/db/get?name=e2123;class=Variation)); [@bib45]), or defective movement and inability to enter a stress-resistant dauer stage (*[unc-119](http://www.wormbase.org/db/get?name=WBGene00006843;class=Gene)*([*ed3*](http://www.wormbase.org/db/get?name=ed3;class=Variation)); [@bib86]; [@bib104]), were used as transformation markers. Again, these markers were the product of laborious genetic screens. Recently, a number of antibiotic resistance cassettes have been developed for *C. elegans*. Use of hygromycin ([@bib106]), puromycin ([@bib113]), and G-418 (geneticin) ([@bib43]) selection identifies and maintains animals with no manual manipulation required. Though these systems require constitutively active promoters to drive expression of the resistance cassette, the *C. elegans* systems use ribosomal protein promoters, which are well conserved in parasites, and standard *C. elegans* 3′-UTRs (*[unc-54](http://www.wormbase.org/db/get?name=WBGene00006789;class=Gene)* or *[let-858](http://www.wormbase.org/db/get?name=WBGene00002957;class=Gene)*). Through a combination of multispecies genomic DNA alignments and expression data, candidate regulatory elements in a parasite of choice can be identified to drive expression of drug resistance cassettes.

CRISPR/Cas9 editing: bringing genetics to the intractable {#s12}
---------------------------------------------------------

CRISPR/Cas9 editing has brought genetics to an ever-increasing number of organisms. The development of CRISPR/Cas9 editing in the protozoan parasite, *Cryptosporidium parvum* highlights many of the challenges that will be involved in developing CRISPR/Cas9 editing in parasitic nematodes. *C. parvum* sporozoites, a motile, spore-like state of Apicomplexan parasites, were transfected with plasmids encoding Cas9 and the sgRNA template, and a luciferase--neomycin resistance fusion gene ([@bib125]). Mice were infected with the transfected sporozoites and subsequently treated with the neomycin analog paromomycin ([@bib125]). Antibiotic-resistant parasites expressing a stably integrated luciferase--neomycin resistance fusion gene were then recovered in the feces of the infected mouse ([@bib125]). These experiments highlight the need for well-characterized regulatory elements, development of antibiotic selection systems to enrich for transgenics, and the challenges implicit to working with an organism that requires passage through a host.

Depending on the parasitic nematode and transgenesis methods available, one can choose between the different approaches previously discussed (RNPs, RNA, DNA). The latter is very cost effective, but requires knowledge of constitutive RNA polymerase II and III promoters for Cas9 and sgRNA expression, respectively. RNPs would be the recommended starting point, as they produce higher editing rates than DNA-based approaches ([@bib102]), and require no knowledge of regulatory elements for a given parasite. Moreover, as a biochemically savvy lab can purify Cas9 and T7 RNA polymerase, this approach could be very cost effective.

An emerging theme in CRISPR/Cas9 editing is that not all sgRNAs are created equal; half of all sgRNAs in *C. elegans* tested have had very low efficiencies ([@bib5]; [@bib66]; [@bib101]). Large-scale genomic screens in mammalian cells have led to algorithms to predict sgRNA efficiency ([@bib29]; [@bib140]). At least one of these algorithms ([@bib29]) has predictive power in *C. elegans* ([@bib60]). The most consistent predictor of highly active sgRNAs is two guanines at the 3′ end of the 20-bp targeting sequence ([@bib32]). With active sgRNAs one occasionally gets homozygous knockout alleles in a single generation, an important point for parasitic nematodes in which mating to homozygose a mutation may be challenging.

Insertion--deletion (indel) mutations, caused by repair of Cas9-induced DNA double-stranded breaks through error-prone nonhomologous end joining (NHEJ) ([Figure 1B](#fig1){ref-type="fig"}), should be the first edits attempted since these occur at high frequency. Once NHEJ-mediated indels are possible in a parasite, one can then try to import homologous recombination-based knockin approaches ([Figure 1B](#fig1){ref-type="fig"}). Using oligonucleotides as repair templates to knock in point mutations and small epitopes has been successful in a range of organisms, including *C. elegans* ([@bib5]; [@bib101]; [@bib145]; [@bib132]) and require no cloning, as they are commercially available. Though PAGE purification boosts editing efficiency, this cost can be avoided if one screens more animals ([@bib132]).

Finding rare knockin animals can pose a "needle in the haystack" type problem; several direct screening approaches have required screening dozens to hundreds of animals ([@bib101]; [@bib145]). To circumvent this issue, *C. elegans* researchers have developed efficient methods to enrich for knockins. Co-conversion/co-CRISPR approaches select for a Cas9-dependent editing event that produces a visible phenotype. Selecting for this marker phenotype enriches for edits at other loci. Markers include mutations that produce abnormal movement \[*[dpy-10](http://www.wormbase.org/db/get?name=dpy-10;class=Gene)*(*[cn64](http://www.wormbase.org/db/get?name=cn64;class=Variation)*), *[rol-6](http://www.wormbase.org/db/get?name=rol-6;class=Gene)*(*[su1006](http://www.wormbase.org/db/get?name=su1006;class=Variation)*), *[unc-22](http://www.wormbase.org/db/get?name=unc-22;class=Gene)* (loss-of-function)\] or repair of a conditional lethal mutation \[*[pha-1](http://www.wormbase.org/db/get?name=pha-1;class=Gene)*(*[e2123](http://www.wormbase.org/db/get?name=e2123;class=Variation)*) ([@bib5]; [@bib66]; [@bib132]\]. Again, these markers were the product of laborious genetic screens and may not be desirable to use in parasites, as they could compromise processes required for propagation. One approach that may work in parasites would be the use of a frame-shifted or mutated FP or drug resistance cassette as a co-CRISPR marker. Selecting for Cas9-mediated edits that restore FP or drug resistance gene expression should enrich for the desired edit. CRISPR/Cas9-mediated restoration of frame-shifted GFP expression has been described in *C. elegans*, but not tested for use as a co-CRISPR marker ([@bib127]). Using RNPs is compatible with co-CRISPR ([@bib102]), which further boosts editing efficiency and minimizes screening.

Alternatively, selection cassettes can be introduced into the knockin construct to select for insertion. Selection markers have included phenotypic markers \[*[unc-119](http://www.wormbase.org/db/get?name=WBGene00006843;class=Gene)* (*+*) or *[sqt-1](http://www.wormbase.org/db/get?name=sqt-1;class=Gene)*(*e1350*); [@bib26]; [@bib25]\], GFP transgenes ([@bib97]), and drug resistance cassettes (hygromycin or G-418) ([@bib13]; [@bib25]; [@bib97]). By flanking the markers with LoxP sites, Cre-mediated excision can be used to remove the cassette. Although this excision leaves a 34-bp insertion, it is often placed within intronic sequences to minimize any deleterious effect to coding regions ([@bib25]; [@bib97]). Cleverly, [@bib25] included the Cre gene under a heat-shock inducible promoter in their "self-excising cassette," which allowed researchers to use hygromycin selection for the knockin, followed by heat shock to remove the cassette. These selection-based schemes are powerful, but require more information about promoters and UTRs, and would take significantly more investment to develop for a given parasite.

CRISPR/Cas9 editing: a critical assessment {#s13}
------------------------------------------

Following the development of RNAi in *C. elegans*, much hope was raised for using this tool for genetic studies in parasitic nematodes. However, recent genomics work has revealed that there is extensive diversity in RNAi and Piwi-interacting RNA (piRNA) biology between *C. elegans* and different nematode species ([@bib20]; [@bib111]). While RNAi has been effective in plant parasitic nematodes, the results in human and animal parasitic nematodes have been variable ([@bib89]). It is therefore important to critically evaluate the chances of CRISPR working in a given parasitic nematode. CRISPR/Cas9 editing efficiency in *C. elegans* depends on the type of edit, location of the DNA double-stranded break, and whether a selection scheme is used; [Table 4](#t4){ref-type="table"} denotes the current range of editing efficiencies with current approaches in *C. elegans*.

###### Current range of CRISPR/Cas9 editing efficiencies in *C. elegans*

  Edit type                                                 Selection                    No. injected   Success rate
  --------------------------------------------------------- ---------------------------- -------------- -------------------------------------------------------------------------------------------------------------------
  Indels                                                    No selection, 3′-GG sgRNAs   7--33          10--72% of screened transgenic marker positive F~1~ ([@bib32])
  Indels                                                    co-CRISPR                    20--40         36--88% of screened co-CRISPR marker positive F~1~ ([@bib66])
  Small knockins (point mutations, stop codons, epitopes)   co-CRISPR                    20--40         8--50% of screened co-CRISPR marker positive F~1~ ([@bib5]; [@bib66]; [@bib132])
  Small knockins (point mutations, stop codons, epitopes)   co-CRISPR, 3′-GG sgRNAs      20--40         30--63% of screened co-CRISPR marker positive F~1~ ([@bib32]; J. D. Ward, unpublished data)
  GFP-sized knockin                                         co-CRISPR                    17--40         50% of screened co-CRISPR marker positive F~1~ ([@bib102])
  GFP-sized knockin                                         co-CRISPR, Cas9 RNP          10--20         2--80% of screened co-CRISPR marker positive F~1~ ([@bib102])
  GFP-sized knockin                                         Drug selection               6--90          0--25% of injected parental animal (due to selection, do not know how many F~1~ are screened ([@bib25]; [@bib97])

Based on these efficiencies, in order to generate small indels or knockins in a given parasite, one would require dozens of transgenics, while larger knockins would require hundreds of transgenics, if not more. Since *C. elegans* hermaphrodites self-fertilize, knockins can be recovered by selecting candidates, allowing them to lay eggs, and genotyping the parental animal. The requirement of host passage and lack of *in vitro* culture for most parasitic nematodes means that one will most likely need to identify knockins through scoring a selectable cointegration marker (*i.e.*, drug resistance or fluorescent markers). Here, I critically review the likelihood of implementing CRISPR/Cas9 editing in the three highlighted parasitic nematodes (*Strongyloides* spp., *Brugia* spp., and *A. suum*).

The best opportunity for generating stable knockins is *S. ratti*. Transgenesis rates of 3.7--7.4% transgenics per F~1~ screened have been reported for *S. ratti*, yielding 6--17 transgenic animals from 40--60 injected parental animals ([@bib78]). For *S. stercoralis*, the transgenesis rates were higher (5.6--33.5%), and more transgenic F~1~'s were obtained (2--204) from a similar number of injected parents when using the same plasmids as in the *S. ratti* experiments ([@bib78]). While *S. ratti* does not tolerate microinjection as well as *S. stercoralis*, 50--100% of infectious *S. ratti* iL3s develop to reproductively active females in five days ([@bib78]); this is in contrast to *S. stercoralis* in which on average only 6.5% of iL3s develop to adult females in a gerbil host ([@bib96]; [@bib59]). Based on transformation efficiency, survival rate, and assuming only 10% of transgenics are germline transformants, [@bib78] estimated that generation of a single germline transformed line would require 167 transgenic iL3s in *S. stercoralis* and 20 transgenic iL3s in *S. ratti*. Based on the number of transgenics typically obtained through gonadal microinjection, it has not yet been possible to establish stable lines in *S. stercoralis* (J. Lok, personal communication).

[@bib116] developed an insertional mutagenesis protocol in *S. ratti* which is instructive about how one would generate stable transgenics using CRISPR/Cas9 editing. Using a GFP-marked cassette, they observed 7.9% GFP-positive animals in the first generation, which went to 0.5% of 6014 animals in the second generation. Through selecting and reinfecting with GFP-positive iL3 animals, the percentage of GFP-positive progeny went to 15.6% in the third generation, 99.0% in the fourth, 82.4% in the fifth, and 98.7% in the sixth ([@bib116]). The lines obtained had stable transgene expression over 10 generations and a number of discrete insertions were obtained ([@bib116]). It would take ∼31 days from initiating a transgenesis experiment to establishment of fourth generation mating pairs, and an additional week to obtain the fifth generation iL3 progeny from this cross (J. Lok, personal communication; [@bib84]). Each additional passage through a rat would take seven days from inoculation of iL3 to recovery of next generation larvae in the feces (J. Lok, personal communication).

For *Brugia* spp., injection of females to transform developing embryos is difficult and can irreversibly damage the animal ([@bib52]), while biolistic transformation of embryos renders them developmentally incompetent ([@bib118]). Calcium phosphate precipitate-mediated transformation of L3 larvae is the remaining avenue for stable transformation. L3 larvae transformed with a *Gaussia* luciferase reporter and subsequently induced to molt *ex vivo* were not able to develop further when inoculated into a jird host ([@bib141]). In contrast, L3s incubated in a calcium phosphate precipitate mix containing the *Gaussia* luciferase reporter and directly inoculated into jirds were able to develop to adulthood, with 60--67% of adults secreting detectable luciferase ([@bib141]). In a typical experiment, 20 adult females and 20 adult males are recovered in the peritoneal cavity from 300-400 injected L3s, (∼10% of L3s develop to adulthood; T. Unnasch, personal communication). A fecund adult female can then produce millions of progeny. Importantly, microfilariae in the next generation expressed the luciferase reporter, with an estimate of 0.47% transgenic animals in the F~1~ population ([@bib141]). This population was fed to the mosquito vector, and L3 larvae expressing the luciferase reporter were obtained, suggesting that the transgene had been maintained through the entire lifecycle ([@bib141]). This generation of transgenics is a significant undertaking: it takes 120--150 days postinoculation to recover adults and microfilariae, and 14 additional days for microfilariae fed to mosquitos to develop to L3s ([@bib141]). Depending on the efficiency of CRISPR/Cas9 editing, these studies suggest that stable transformation may by feasible but will depend on transformation efficiency. It would also be critical to develop selectable markers, such as fluorescent reporters or drug selection cassettes, to identify transgenic animals.

A strength of *A. suum* as a model is its extreme fecundity; females can produce 200,000 eggs per day, and one can biolistically transform 700,000 embryos. Though the lack of fluorescent markers makes it difficult to determine transformation efficiency, 30--40% of embryos are hit with gold particles in a typical bombardment experiment (R. E. Davis, personal communication). These experiments are typically performed on 32- to 64-cell embryos, which will make any transgenics mosaic and decrease the chance of obtaining a stable line ([@bib23]). Ideally, one would bombard 1-cell stage embryos, but these would fail to develop, and the incredibly robust permeability barrier prevents other approaches such as electroporation (R. E. Davis, personal communication). The development of RNAi protocols by injection may pave the way for new methods of germline transformation, which would increase the chances of obtaining a stable knockin ([@bib90]). It is important to note a major barrier to stable transgenesis in *Ascaris* is that most labs obtain adult worms from local slaughterhouses; there are likely only a handful of labs that maintain the lifecycle in the pig. If stable transgenesis is attempted, it would take 3--4 weeks for the embryos to develop to L2 larvae and 2--3 months for the development of fertile adults.

The longer lifecycles and potential requirement for multiple host passages to obtain stable knockins poses a significant challenge to implementing these tools, which may be insurmountable for many parasites. There are several approaches through which one could circumvent some of these issues. Generating homozygotes in F~1~ transgenics using a "mutagenic chain reaction" ([@bib38]), would limit the need for multiple passages and mating to establish a line. This system consists of a cassette containing a Cas9 transgene, an sgRNA targeting a specific genomic locus of interest, and homology flanking the sgRNA target site. The cassette can be used as a template for repair of the Cas9-induced DSB resulting in insertion of the cassette at the break site. Cas9 and the sgRNA can then be expressed from the cassette and result in a DSB in the homologous chromosome, and insertion of the cassette into this chromosome through homologous recombination, resulting in a homozygote for the cassette insertion. Gene drive systems are controversial due to the risk of inadvertently altering wild population genetic diversity, and their use requires ethical oversight and best practice guidelines to prevent an inappropriate biological release ([@bib4]).

An important consideration in importing CRISPR/Cas9 editing into parasites is that many genes of interest for vaccine or drug targets will be essential for critical aspects of host--parasite interaction such as invasion, migration through tissues, and adult longevity. Mutations in these types of genes would be difficult, if not impossible to propagate as they could render the parasite innocuous. Another option would be to implement CRISPR/Cas9 methodology variations that allow assays to be performed in first generation transgenic animals. Somatic editing using CRISPR/Cas9 in *C. elegans* appears much more robust than germline editing: for five genes tested, 86--97% penetrance of a known recessive phenotype were observed, with targeting of one gene producing a less penetrant phenotype (20% of animals) ([@bib117]). Alternatively, one could activate or repress target gene expression through CRISPR activation (CRISPRa) or CRISPR interference (CRISPRi), respectively ([@bib105]; [@bib41]). These methods use the fusion of a transcriptional activator or repressor to a nuclease-dead Cas9 protein. With somatic editing or CRISPRa/i, one could score a phenotype of interest relative to a control and then sacrifice the animals to experimentally confirm CRISPR efficiency. Somatic mutations can be detected by PCR followed by digestion with mismatch cutting nucleases such as CEL-1 or T7E1, while gene expression changes can be detected by qRT-PCR. These approaches will rely on expression of Cas9 and the sgRNAs from promoters of interest. One could add an additional level of control through use of conditional systems such as the drug-inducible, split-Cas9 system ([@bib144]). In this approach, Cas9 is split into two fragments that are each fused to rapamycin-binding dimerization domains ([@bib144]). Cas9 is inactive until rapamycin is added, bringing the two fragments into proximity. This system could be expressed under either ubiquitous or tissue-specific promoter to allow genetic manipulation with temporal control. Such an approach could be used to study specific aspects of parasitism, such as tissue invasion or migration in first generation transgenic animals.

Future Perspectives {#s14}
===================

The import of these approaches combined with other technologies such as deep sequencing and mass spectrometry will synergize and allow extremely rapid progress on a range of biomedically and agriculturally important parasites. In [Figure 2](#fig2){ref-type="fig"}, I suggest a workflow for stepwise development of tools in a given parasitic nematode, starting with basic transgenesis methods and FP reporters, and building to sophisticated genome editing tools. This workflow represents a significant investment in time and money and would be best undertaken by groups of researchers. The payoff from such a development scheme would be worthwhile as it could aid discovery of novel interventions. For example, one could generate fluorescent reporters to readout pathway activity, which could allow for more targeted drug screening. Developing genetics in these parasites also presents a rich opportunity for evo--devo studies; studying both *C. elegans* and a parasitic nematode is a win--win, as conserved pathways can be dissected in *C. elegans* and a researcher can toggle back and forth between the model and the parasite. Nonconserved pathways are interesting from an evolutionary perspective, as one can explore how selective pressure may have shaped these differences. There are incredible open questions waiting to be explored spanning the biology and evolution of host--parasite and parasite--vector interactions. Parasites often have unique sets of genes, some of which are likely central to the unique lifecycle and biology of a given parasite, and we need robust new tools to explore their function. Finally, the intimate interaction of parasites with their cognate host offers potential insight into our own biology. The study of phage allowed us to probe bacterial transcription and gene regulation, and work on *Listeria* revealed mechanisms underlying mammalian cytoskeletal dynamics. The range of parasites with specific lifecycles, target tissues, and unique gene products to modulate host pathways is an incredibly rich experimental vein to tap. We just need to develop the right tools to realize this potential.
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